SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
03-Apr-24 4:02 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 02-Apr-24 | Sale (Planned) | 240 | $419.00 | $100,560.00 | (3%) 7.74K to 7.5K | |
03-Apr-24 4:02 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-Apr-24 | Payment of Exercise | 225 | $418.10 | $94,072.50 | (3%) 7.96K to 7.74K | |
27-Feb-24 4:29 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 26-Feb-24 | Sale (Planned) | 883 | $425.70 | $375,893.00 | (10%) 8.85K to 7.96K | |
27-Feb-24 4:29 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 23-Feb-24 | Payment of Exercise | 828 | $431.79 | $357,522.00 | (9%) 9.68K to 8.85K | |
13-Feb-24 4:48 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 12-Feb-24 | Sale (Planned) | 1,374 | $420.24 | $577,410.00 | (12%) 11.05K to 9.68K | |
13-Feb-24 4:48 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 09-Feb-24 | Payment of Exercise | 591 | $422.74 | $249,839.00 | (5%) 11.64K to 11.05K | |
08-Feb-24 4:20 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 07-Feb-24 | Grant | 1,853 | -- | -- | 19% 9.79K to 11.64K | |
08-Feb-24 4:20 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 06-Feb-24 | Grant | 2,950 | -- | -- | 43% 6.84K to 9.79K | |
01-Jun-23 4:12 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 30-May-23 | Private Sale (Planned) | 289 | $329.82 | $95,318.00 | (4%) 7.13K to 6.84K | |
04-Apr-23 10:00 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 31-Mar-23 | Payment of Exercise | 176 | $313.74 | $55,218.20 | (2%) 7.3K to 7.13K | |
28-Feb-23 4:44 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 27-Feb-23 | Sale (Planned) | 1,207 | $287.55 | $347,072.00 | (14%) 8.51K to 7.3K | |
28-Feb-23 4:44 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 24-Feb-23 | Payment of Exercise | 502 | $289.12 | $145,138.00 | (6%) 9.01K to 8.51K | |
03-Feb-23 10:00 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-Feb-23 | Grant | 5,516 | -- | -- | 158% 3.5K to 9.01K | |
27-Apr-22 4:05 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 25-Apr-22 | Private Sale (Planned) | 327 | $269.55 | $88,143.00 | (9%) 3.82K to 3.5K | |
05-Apr-22 4:06 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-Apr-22 | Payment of Exercise | 137 | $263.09 | $36,043.30 | (3%) 3.96K to 3.82K | |
03-Feb-22 4:09 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-Feb-22 | Grant | 2,566 | -- | -- | 184% 1.39K to 3.96K |